Updated Phase 1 data for ELVN-001 expected mid-2025 as positive enrollment momentum continues Expected monotherapy and combination data from the ELVN-002 Phase 1 trials ...
Roche programmeOver 32,000 new breast cancer cases are expected in Nigeria in the ongoing year,the Global Cancer Observatory,GCO, has said .The interactive web-based platform presenting global cancer ...
Dr. Kevin Kalinsky discusses the role of targeted therapy and clinical decision-making in managing estrogen-driven, ...